Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
M. A. Pfaller, R. E. Mendes, H. S. Sader, M. Castanheira & C. G. Carvalhaes. (2023) Oritavancin in vitro activity against Gram-positive organisms from European medical centers: a 10-year longitudinal overview from the SENTRY Antimicrobial Surveillance Program (2010–2019). Journal of Chemotherapy 35:8, pages 689-699.
Read now
Read now
Guillermo Jose Vazquez-Rosas, Jocelin Merida-Vieyra, Gerardo Aparicio-Ozores, Antonino Lara-Hernandez, Agustin De Colsa & Alejandra Aquino-Andrade. (2021) Molecular Characterization of Staphylococcus aureus Obtained from Blood Cultures of Paediatric Patients Treated in a Tertiary Care Hospital in Mexico. Infection and Drug Resistance 14, pages 1545-1556.
Read now
Read now
Olaniyi Ayobami, Niklas Willrich, Annicka Reuss, Tim Eckmanns & Robby Markwart. (2020) The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections. Emerging Microbes & Infections 9:1, pages 1180-1193.
Read now
Read now
Petros I Rafailidis & Matthew E Falagas. (2019) Addressing clinical safety of antimicrobial resistance: personal perspectives. Expert Review of Anti-infective Therapy 17:11, pages 865-869.
Read now
Read now
Matteo Bassetti, Alessandro Russo, Alessia Carnelutti & Mark Wilcox. (2019) Emerging drugs for treating methicillin-resistant Staphylococcus aureus. Expert Opinion on Emerging Drugs 24:3, pages 191-204.
Read now
Read now